- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00447655
Improving Outcomes Following Limb Loss: PALS Plus (PALS-PLUS)
12 de dezembro de 2017 atualizado por: Johns Hopkins University
Limb loss can result from a variety of etiologies including diabetes, trauma and cancer.
Following limb loss, individuals are at elevated risk for activity limitations and participation restrictions with significant impact on health and quality of life.
Intervention: Working with the Amputee Coalition of America we have developed, evaluated, and established the effectiveness of a self-management program (PALS) to improve health and outcomes following limb loss.
Literature suggests that the access to, and effectiveness and utilization of, this class of interventions may be enhanced by the concerted use of early intervention, peer mentorship, motivational interviewing and provider training.
Objectives: Our goal is to evaluate the effectiveness of an enhanced, early self-management intervention- PALS Plus.
The specific aims are:1) evaluate the effectiveness of the PALS Plus intervention in improving outcomes for persons with limb loss; (2) evaluate the effectiveness of the PALS Plus intervention in maximizing utilization of self-management interventions for persons with limb loss.
A cohort of 200 patients will be enrolled prior to implementation of the intervention and will serve as the control group.
Subsequently, a second cohort of 200 patients will be enrolled and receive the PALS Plus intervention and will serve as the intervention group.
Assessment will be at baseline, treatment completion and six month follow-up.
Outcomes: Primary outcome measures are: pain, depressed mood, and positive mood.
Secondary outcome measures are: function, participation and bothersomeness of limitations.
The investigation will also provide unique and valuable information regarding patients' acceptance and use of peer visitation and self-management following limb loss.
Relevance: By establishing the utility and effectiveness of the enhanced self-management intervention, there is the potential to improve the health, activity, participation and quality of life for individuals with disabilities.
The intervention addresses the areas of activity and participation in such a way that it can be implemented in local health care facilities working in combination with a national consumer based organization - the Amputee Coalition of America.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
Limb loss can result from a variety of etiologies including diabetes, trauma and cancer.
Following limb loss, individuals are at elevated risk for activity limitations and participation restrictions with significant impact on health and quality of life.
Intervention: Working with the Amputee Coalition of America we have developed, evaluated, and established the effectiveness of a self-management program (PALS) to improve health and outcomes following limb loss.
Literature suggests that the access to, and effectiveness and utilization of, this class of interventions may be enhanced by the concerted use of early intervention, peer mentorship, motivational interviewing and provider training.
Objectives: Our goal is to evaluate the effectiveness of an enhanced, early self-management intervention- PALS Plus.
The specific aims are:1) evaluate the effectiveness of the PALS Plus intervention in improving outcomes for persons with limb loss; (2) evaluate the effectiveness of the PALS Plus intervention in maximizing utilization of self-management interventions for persons with limb loss.
Study Design and Participants: The prospective clinical trial will use a two group, lagged-control design to evaluate the intervention at five health care facilities.
A cohort of 200 patients will be enrolled prior to implementation of the intervention and will serve as the control group.
Subsequently, a second cohort of 200 patients will be enrolled and receive the PALS Plus intervention and will serve as the intervention group.
Assessment will be at baseline, treatment completion and six month follow-up.
Outcomes: Primary outcome measures are: pain, depressed mood, and positive mood.
Secondary outcome measures are: function, participation and bothersomeness of limitations.
Improvements in primary and secondary outcomes will result through the impact on self efficacy, patient activation, catastrophizing and social support.
The investigation will also provide unique and valuable information regarding patients' acceptance and use of peer visitation and self-management following limb loss.
Relevance: By establishing the utility and effectiveness of the enhanced self-management intervention, there is the potential to improve the health, activity, participation and quality of life for individuals with disabilities.
The intervention addresses the areas of activity and participation in such a way that it can be implemented in local health care facilities working in combination with a national consumer based organization - the Amputee Coalition of America.
Tipo de estudo
Intervencional
Inscrição (Real)
400
Estágio
- Fase 2
- Fase 1
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21239
- Good Samaritan Hospital
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos a 85 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Adults (aged 18-85 years) of both sexes and all races admitted to one of the seven participating acute care hospitals or rehabilitation facilities for an amputation procedure and/or treatment immediately following an amputation procedure, including traumatic amputations as well as amputations due to complications for diabetes mellitus, peripheral vascular disease, and malignancy.
- Women and minority patients will be represented in the trial according to the gender and race/ethnic prevalence of patients receiving treatment at the designated hospital and rehabilitation centers.
Exclusion Criteria:
Criteria for exclusion from the study will include:
- Age less than 18 or over 85 years; and
- Inability to communicate in written or spoken English.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
|---|
|
Primary outcome measures are: pain, depressed mood, and positive mood.
|
Medidas de resultados secundários
Medida de resultado |
|---|
|
Secondary outcome measures are: function, participation and bothersomeness of limitations
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Stephen T Wegener, PHD, Johns Hopkins University
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo
1 de março de 2007
Conclusão Primária (Real)
1 de agosto de 2009
Conclusão do estudo (Real)
1 de agosto de 2009
Datas de inscrição no estudo
Enviado pela primeira vez
14 de março de 2007
Enviado pela primeira vez que atendeu aos critérios de CQ
14 de março de 2007
Primeira postagem (Estimativa)
15 de março de 2007
Atualizações de registro de estudo
Última Atualização Postada (Real)
13 de dezembro de 2017
Última atualização enviada que atendeu aos critérios de controle de qualidade
12 de dezembro de 2017
Última verificação
1 de dezembro de 2017
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- CDC R01DD000153
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .